Audio: Transcript: INVINCIBLE Trial: INT230-6 Triggers Tumor Necrosis In Vivo – Nicholas Coupe, MBBS @nickcoupe123 @OUHospitals #ASCO22 #OncoTwitter Non-Small Cell Lung Cancer 3 Mins Read0 Audio: Thank you, thanks for the question so this study titled IMP is an early phase dose-escalation study first in…
Melanoma & CD8 Killer T Cells Non-Small Cell Lung Cancer 7 Mins Read0 INT230-6 is an early phase dose-escalation study first in hand study evaluating effectiveness of a new compound called PORT-2 now…
Audio: Transcript: INVINCIBLE Trial: INT230-6 Triggers Tumor Necrosis In Vivo – Nicholas Coupe, MBBS @nickcoupe123 @OUHospitals #ASCO22 #OncoTwitter Non-Small Cell Lung Cancer 5 Mins Read0  Article: Transcript: Question – Please Tell Us About the INVINCIBLE Trial.  Thank you, thanks for the question so…
